DDInter499 DDInter875
A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces cerevisiae* and self-assembled into VLPs.
Denileukin diftitox {u} may cause a minor interaction that can limit clinical effects when taken with {v} Moxifloxacin
Denileukin diftitox {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Zidovudine
Denileukin diftitox {u} may lead to a major life threatening interaction when taken with {v} Measles virus vaccine live attenuated
Denileukin diftitox may cause a minor interaction that can limit clinical effects when taken with Moxifloxacin
Denileukin diftitox may cause a moderate interaction that could exacerbate diseases when taken with Zidovudine
Denileukin diftitox may lead to a major life threatening interaction when taken with Measles virus vaccine live attenuated